Coreg cr and Simvastatin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Coreg cr (carvedilol phosphate) and Simvastatin (simvastatin). Common drug interactions include heart rate increased among females and abnormal behaviour among males.

The phase IV clinical study analyzes what interactions people have when they take Coreg cr and Simvastatin. It is created by eHealthMe based on reports of 56 people who take the same drugs from the FDA, and is updated regularly.

What is Coreg cr?

Coreg cr has active ingredients of carvedilol phosphate. It is often used in high blood pressure. eHealthMe is studying from 1,628 Coreg cr users. Check the latest studies of Coreg cr.

What is Simvastatin?

Simvastatin has active ingredients of simvastatin. It is often used in high blood cholesterol. eHealthMe is studying from 256,969 Simvastatin users. Check the latest studies of Simvastatin.



On Jul, 05, 2026

56 people who take Coreg cr and Simvastatin together, and have interactions are studied.

Coreg cr and Simvastatin drug interactions.

What are the common drug interactions of Coreg Cr and Simvastatin, by gender? *:

female:

  1. Heart rate increased
  2. Herpes zoster
  3. Hypotension (abnormally low blood pressure)
  4. Increased appetite
  5. Lymphadenopathy (disease or enlargement of lymph nodes)
  6. Memory impairment
  7. Mobility decreased (ability to move is reduced)
  8. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  9. Nodule (a growth of abnormal tissue)
  10. Oropharyngeal pain

male:

  1. Abnormal behaviour
  2. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  3. Cardiac failure congestive
  4. Diarrhoea
  5. Drug ineffective
  6. Hyperlipidaemia (presence of excess lipids in the blood)
  7. International normalised ratio increased
  8. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  9. Chronic kidney disease
  10. Acute myocardial infarction (acute heart attack)

What are the common drug interactions of Coreg Cr and Simvastatin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Accident at work
  2. Loss of consciousness
  3. Partial seizures (seizures which affect only a part of the brain at onset)
  4. Anaemia (lack of blood)
  5. Drug effect decreased
  6. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  7. Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)
  8. Sinusitis (inflammation of sinus)

50-59:

  1. Diabetic foot
  2. Wound infection staphylococcal
  3. Chronic kidney disease
  4. Drug hypersensitivity
  5. Peripheral swelling
  6. Acute myocardial infarction (acute heart attack)
  7. Drug administration error
  8. Dyspnoea (difficult or laboured respiration)
  9. Dyspnoea exertional (breathlessness or shortness of breath)
  10. Heart rate increased

60+:

  1. Asthenia (weakness)
  2. Abnormal behaviour
  3. Weight decreased
  4. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  5. Dementia (madness)
  6. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  7. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  8. Fall
  9. Hyperlipidaemia (presence of excess lipids in the blood)
  10. Injection site atrophy (injection site wasting or decreasing in size of a body organ, tissue, or part)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 9 people, 16.07%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 8 people, 14.29%
  3. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 6 people, 10.71%
  4. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 7.14%
  5. Multiple Myeloma (cancer of the plasma cells): 4 people, 7.14%
  6. Stable Angina (a constant chest pain): 3 people, 5.36%
  7. Gout (uric acid crystals building up in the body): 3 people, 5.36%
  8. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 5.36%

* Approximation only. Some reports may have incomplete information.

Do you take Coreg cr and Simvastatin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Coreg cr and Simvastatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Coreg cr:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Simvastatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Coreg cr and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Simvastatin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on carvedilol phosphate and simvastatin (the active ingredients of Coreg cr and Simvastatin, respectively), and Coreg cr and Simvastatin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: